Gene · 2249
Papers3,660
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,341 to 1,360 of 3,660
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Phosphoproteomics identifies a bimodal EPHA2 receptor switch that promotes embryonic stem cell differentiation. | Nat Commun | 2020 | 32170114 | PubTator, text mining | PubMed |
| ATR expands embryonic stem cell fate potential in response to replication stress. | Elife | 2020 | 32163370 | PubTator, text mining | PubMed |
| Fibroblast Growth Factor 9 is expressed by activated hepatic stellate cells and promotes progression of hepatocellular carcinoma. | Sci Rep | 2020 | 32161315 | PubTator, text mining | PubMed |
| LY75 Ablation Mediates Mesenchymal-Epithelial Transition (MET) in Epithelial Ovarian Cancer (EOC) Cells Associated with DNA Methylation Alterations and Suppression of the Wnt/β-Catenin Pathway. | Int J Mol Sci | 2020 | 32156068 | PubTator, text mining | PubMed |
| Stimulation of L-type calcium channels increases tyrosine hydroxylase and dopamine in ventral midbrain cells induced from somatic cells. | Stem Cells Transl Med | 2020 | 32154672 | PubTator, text mining | PubMed |
| Targeting the pregnane X receptor using microbial metabolite mimicry. | EMBO Mol Med | 2020 | 32153125 | PubTator, text mining | PubMed |
| Secretome of Senescent Adipose-Derived Mesenchymal Stem Cells Negatively Regulates Angiogenesis. | Int J Mol Sci | 2020 | 32151085 | PubTator, text mining | PubMed |
| Refractory solitary cervical lymph node metastasis after esophageal squamous cell carcinoma surgery and its successful treatment with immune checkpoint inhibitor: A case report and literature review. | Medicine (Baltimore) | 2020 | 32150096 | PubTator, text mining | PubMed |
| GATA4 Is Required for Budding Morphogenesis of Posterior Foregut Endoderm in a Model of Human Stomach Development. | Front Med (Lausanne) | 2020 | 32140468 | PubTator, text mining | PubMed |
| FGF Signaling Pathway: A Key Regulator of Stem Cell Pluripotency. | Front Cell Dev Biol | 2020 | 32133359 | PubTator, text mining | PubMed |
| Genome-wide CRISPR screen identifies ZIC2 as an essential gene that controls the cell fate of early mesodermal precursors to human heart progenitors. | Stem Cells | 2020 | 32129551 | PubTator, text mining | PubMed |
| FGF/FGFR signaling pathway involved resistance in various cancer types. | J Cancer | 2020 | 32127928 | PubTator, text mining | PubMed |
| Development of genetic quality tests for good manufacturing practice-compliant induced pluripotent stem cells and their derivatives. | Sci Rep | 2020 | 32127560 | PubTator, text mining | PubMed |
| The CaSR in Pathogenesis of Breast Cancer: A New Target for Early Stage Bone Metastases. | Front Oncol | 2020 | 32117726 | PubTator, text mining | PubMed |
| Enhanced autocrine FGF19/FGFR4 signaling drives the progression of lung squamous cell carcinoma, which responds to mTOR inhibitor AZD2104. | Oncogene | 2020 | 32111983 | PubTator, text mining | PubMed |
| Network modeling of patients' biomolecular profiles for clinical phenotype/outcome prediction. | Sci Rep | 2020 | 32107391 | PubTator, text mining | PubMed |
| Retrotransposons Manipulating Mammalian Skeletal Development in Chondrocytes. | Int J Mol Sci | 2020 | 32106563 | PubTator, text mining | PubMed |
| Comparison of commercially available media for hepatic differentiation and hepatocyte maintenance. | PLoS One | 2020 | 32106262 | PubTator, text mining | PubMed |
| A comparison of hepato-cellular in vitro platforms to study CYP3A4 induction. | PLoS One | 2020 | 32106230 | PubTator, text mining | PubMed |
| Helicobacter Pylori Targets the EPHA2 Receptor Tyrosine Kinase in Gastric Cells Modulating Key Cellular Functions. | Cells | 2020 | 32102381 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2249/papers?page=68